📢 Important Update: Mounjaro (Tirzepatide) Weight Loss Injections
We’ve received a high volume of enquiries recently following media coverage of Mounjaro (Tirzepatide). Please note that this treatment is currently not available for prescribing by GPs, and we are awaiting further guidance from our ICB (Integrated Care Board).
🔍 Eligibility Criteria (for future consideration):
To be considered for treatment when available, patients must meet all the following:
✅ BMI over 40
OR
BMI over 37.5 for individuals from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds
✅ Completion of at least 2 years in a Tier 2 weight management programme
✅ At least 4 out of 5 of the following conditions:
· Hypertension
· Atherosclerotic cardiovascular disease
· Obstructive sleep apnoea
· Dyslipidaemia
· Type 2 diabetes
⚠️ Access will be subject to ICB Prior Approval. This medication cannot be prescribed on request or without proper assessment.
📞 Please do not contact the practice to request Mounjaro at this time. We will reach out to eligible patients directly once guidance is received.
❌ If you do not meet the strict criteria, appointments to discuss weight loss injections will not be booked.
🔒 For those exploring private treatment, please contact private providers directly. Unfortunately, we are unable to assist with private access or offer advice on private options, monitoring, or providers.
🙏 Thank you for your patience and understanding.